Impact of Sarcopenia on Adverse Outcomes After Allogeneic Hematopoietic Cell Transplantation

BACKGROUND: High intensity treatments such as hematopoietic cell transplantation (HCT) can be curative for patients with hematologic malignancies, but this needs to be balanced by the high risk of nonrelapse mortality (NRM) during the first 2 years after HCT. Sarcopenia (low muscle mass) is associat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: Armenian, Saro H, Xiao, Meisi, Berano Teh, Jennifer, Lee, Brandyn, Chang, Howard A, Mascarenhas, Kristen, Lee, Sean, Iukuridze, Alex, Xie, Jack J, Scott, Jessica M, Jones, Lee W, Lennie Wong, F, Forman, Stephen J, Nakamura, Ryotaro
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6695315/
https://ncbi.nlm.nih.gov/pubmed/30951603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djy231
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados